These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 29697592
1. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy. Marchese A, Miserocchi E, Modorati G, Querques G, Bandello F. Retina; 2018 Jul; 38(7):e53-e54. PubMed ID: 29697592 [No Abstract] [Full Text] [Related]
2. Diagnostic and Therapeutic Challenges. La Spina C, Modorati GM, Bandello F, Querques G, Roberts P, Fawzi AA. Retina; 2018 Feb; 38(2):432-437. PubMed ID: 28272282 [No Abstract] [Full Text] [Related]
3. Microrip of Retinal Pigment Epithelium in Central Serous Chorioretinopathy. Ranjan R, Agarwal M, Verma N. JAMA Ophthalmol; 2020 Jun 01; 138(6):e193120. PubMed ID: 32525538 [No Abstract] [Full Text] [Related]
4. Central Serous Chorioretinopathy. Daruich A, Matet A, Behar-Cohen F. Dev Ophthalmol; 2017 Jun 01; 58():27-38. PubMed ID: 28351043 [Abstract] [Full Text] [Related]
5. Relapsing Pigment Epithelial Detachment in Central Serous Chorioretinopathy After Dilated Eye Examination. German O, Jampol LM. JAMA Ophthalmol; 2020 Oct 01; 138(10):1106-1107. PubMed ID: 32880606 [No Abstract] [Full Text] [Related]
6. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes. Shinojima A, Mehanna C, Lavia CA, Gaudric A, Tadayoni R, Bousquet E. Br J Ophthalmol; 2020 Jun 01; 104(6):852-856. PubMed ID: 31473627 [Abstract] [Full Text] [Related]
7. Effect of Serous Retinal Detachment on the Measurement of Axial Length in Central Serous Chorioretinopathy. Shin YI, Won YK, Shin KS, Jo YJ, Kim JY. Korean J Ophthalmol; 2019 Feb 01; 33(1):63-69. PubMed ID: 30746913 [Abstract] [Full Text] [Related]
8. Masqueraders of central serous chorioretinopathy. Sahoo NK, Singh SR, Rajendran A, Shukla D, Chhablani J. Surv Ophthalmol; 2019 Feb 01; 64(1):30-44. PubMed ID: 30243734 [Abstract] [Full Text] [Related]
9. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy]. Doga AV, Klepinina OB, Pedanova EK, Mushkova IA. Vestn Oftalmol; 2017 Feb 01; 133(6):10-15. PubMed ID: 29319664 [Abstract] [Full Text] [Related]
10. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy. Ooto S, Tsujikawa A, Mori S, Tamura H, Yamashiro K, Otani A, Yoshimura N. Retina; 2011 Mar 01; 31(3):527-34. PubMed ID: 20890237 [Abstract] [Full Text] [Related]
11. Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy. Hasanreisoglu M, Gulpinar Ikiz GD, Kucuk H, Varan O, Ozdek S. Int Ophthalmol; 2018 Feb 01; 38(1):369-374. PubMed ID: 28050729 [Abstract] [Full Text] [Related]
12. Detection of secondary choroidal neovascularization in chronic central serous chorioretinopathy by swept source-optical coherence tomography angiography. Stattin M, Ahmed D, Forster J, Glittenberg C, Herrmann M, Krebs I, Ansari-Shahrezaei S. Acta Ophthalmol; 2019 Feb 01; 97(1):e135-e136. PubMed ID: 30284407 [No Abstract] [Full Text] [Related]
13. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography. De Bats F, Cornut PL, Wolff B, Kodjikian L, Mauget-Faÿsse M. Eur J Ophthalmol; 2018 Jul 01; 28(4):446-453. PubMed ID: 29554817 [Abstract] [Full Text] [Related]
14. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy. Matsumoto H, Kishi S, Sato T, Mukai R. Am J Ophthalmol; 2011 Apr 01; 151(4):617-623.e1. PubMed ID: 21257153 [Abstract] [Full Text] [Related]
15. Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report. Al-Awadi A, Mandelcorn ED, Somani S. Can J Ophthalmol; 2017 Feb 01; 52(1):e38-e41. PubMed ID: 28237171 [No Abstract] [Full Text] [Related]
16. Spectral domain optical coherence tomography and angiographic findings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids. Arantes TE, Garcia CR, Rossi MR, Muccioli C. Ocul Immunol Inflamm; 2009 Feb 01; 17(5):316-8. PubMed ID: 19831561 [Abstract] [Full Text] [Related]
17. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Int Ophthalmol; 2017 Jun 01; 37(3):483-489. PubMed ID: 27392913 [Abstract] [Full Text] [Related]
18. Diagnostic and therapeutic challenges. De Salvo G, Keane PA, Tufail A, Sarraf D. Retina; 2015 Feb 01; 35(2):374-7. PubMed ID: 24732696 [No Abstract] [Full Text] [Related]
19. Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant. Noh GM, Nam KY, Lee SU, Lee SJ. Korean J Ophthalmol; 2019 Aug 01; 33(4):392-394. PubMed ID: 31389218 [No Abstract] [Full Text] [Related]
20. Detection of shallow detachments in central serous chorioretinopathy. Wang M, Sander B, Lund-Andersen H, Larsen M. Acta Ophthalmol Scand; 1999 Aug 01; 77(4):402-5. PubMed ID: 10463409 [Abstract] [Full Text] [Related] Page: [Next] [New Search]